drugset / Trial / NCT01327664
Study to Evaluate the Long Term Use of Treatment With AIN457 for Uveitis
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This study will provide patients who have completed the AIN457 Phase II and Phase III clinical trials in non-infectious uveitis continued access to treatment with AIN457 while collecting safety data and information on long term clinical use of treatment with AIN457.
Timeline
- Start
- 2011-03
- Primary completion
- 2014-05
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Secukinumab | Monoclonal antibody | 300 mg | Subcutaneous |